Lisata Therapeutics, Inc. 0HS8.L Stock
Lisata Therapeutics, Inc. Price Chart
Lisata Therapeutics, Inc. 0HS8.L Financial and Trading Overview
| Lisata Therapeutics, Inc. stock price | 2.96 USD |
| Previous Close | 4.27 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 10.59 USD |
| Volume | 5.85K USD |
| Avg. Volume | 243 USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.217253 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.394 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0HS8.L Valuation Measures
| Enterprise Value | -25728716 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5791891 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.942 |
Trading Information
Lisata Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.217253 |
| 52-Week Change | -45.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.59 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 4.62 USD |
| 200-Day Moving Average | 4.75 USD |
0HS8.L Share Statistics
| Avg. Volume (3 month) | 243 USD |
| Avg. Daily Volume (10-Days) | 183 USD |
| Shares Outstanding | N/A |
| Float | 6.63M |
| Short Ratio | N/A |
| % Held by Insiders | 2.27% |
| % Held by Institutions | 10.37% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.066667:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.73% |
| Return on Equity (ttm) | -75.44% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -27322000 USD |
| Net Income Avi to Common (ttm) | -56186000 USD |
| Diluted EPS (ttm) | -0.394 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 61.1M USD |
| Total Cash Per Share (mrq) | 7.66 USD |
| Total Debt (mrq) | 421K USD |
| Total Debt/Equity (mrq) | 0.69 USD |
| Current Ratio (mrq) | 12.353 |
| Book Value Per Share (mrq) | 7.621 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -23724000 USD |
| Levered Free Cash Flow (ttm) | -14257000 USD |
Profile of Lisata Therapeutics, Inc.
| Country | United Kingdom |
| State | NJ |
| City | Basking Ridge |
| Address | 110 Allen Road |
| ZIP | 07920 |
| Phone | 908 842 0100 |
| Website | https://www.lisata.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 27 |
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 1b/2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; HONEDRA, a recipient of SAKIGAKE designation critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and LSTA201, a CD34+ cell therapy for the treatment of chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Q&A For Lisata Therapeutics, Inc. Stock
What is a current 0HS8.L stock price?
Lisata Therapeutics, Inc. 0HS8.L stock price today per share is 2.96 USD.
How to purchase Lisata Therapeutics, Inc. stock?
You can buy 0HS8.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lisata Therapeutics, Inc.?
The stock symbol or ticker of Lisata Therapeutics, Inc. is 0HS8.L.
How many shares does Lisata Therapeutics, Inc. have in circulation?
The max supply of Lisata Therapeutics, Inc. shares is 0.
What is Lisata Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Lisata Therapeutics, Inc. PE Ratio is now.
What was Lisata Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Lisata Therapeutics, Inc. EPS is -0.394 USD over the trailing 12 months.